HIV AIDS

Previous studies have established that early treatment of HIV dramatically reduces the odds of spreading the infection to a sexual partner. The START trial provides evidence that early therapy benefits a patient's own health.

Interest in preexposure prophylaxis is high among a diverse population of men who have sex with men who are at risk for HIV infection.

A large increase in HIV and HCV infections in Indiana among injection drug users has prompted the CDC to issue a nationwide public health alert. Here's what you can do.

Rates of postoperative mortality among HIV-infected individuals who are receiving ART are low and influenced as much by hypoalbuminemia and age as by CD4 cell status, according to a new study.

Screening for tobacco use and strategies for quitting are important considerations for patients with HIV, since infected adults are more likely to smoke -- and less likely to quit -- than those who are uninfected.

A new study shows that it is safe to fall back on an NRTI-only regimen in special circumstances in patients with adequately suppressed HIV replication.

HIV infection increases the risk of acute myocardial infarction in veterans without major cardiovascular disease risk factors. The presence of major CVD risk factors significantly increases this risk.

CROI offers more than 1100 high-quality presentations and myriad poster sessions. You have so little time. Our CROI blogger offers 6 different ways to maximize learning at any jam-packed meeting, depending on your personal style.

The antiviral future holds great promise for people living with HIV: better-tolerated, less toxic, drugs are about to come to market, and we are about to see the introduction of drugs from 1 or 2 new classes.

Here is compelling reason why every MD needs to test his or her patients for HCV, and get them into therapy as soon as possible.

Here’s a look at how emergency room experiences affect linkage to care and retention in care among patients with HIV.

Here: an update on progress and challenges in HIV eradication, and a focus on the efforts of the President’s Emergency Plan for AIDS Relief.

Is pre-exposure prophylaxis an effective means of reducing the number of new HIV infections?

Do we, in resource-rich countries, have the will and the resources to spend on HIV or HCV eradication? We have the tools (medications), but the goal of eradicating both infections seems as elusive as ever.

HIV-infected men appear to be using testosterone replacement without adequate baseline evaluation and establishment of recommended indications.

Here's why it is important for everyone infected with HIV to get an influenza vaccination.

“Enough time” is one of the necessary components of what it takes to be a “good” doctor. Here’s how this doctor defines “enough.”

Abrasions, ecchymoses, and a 3-cm laceration led to infection with Morganella morganii. What do you know about this pathogen? In this quiz: questions on wounds that resulted from falls.

Statins effectively lower levels of various pro-inflammatory markers of immune activation. So can statin therapy prevent CVD events in HIV-infected persons?

Details here about a quick reference guide for HIV primary care clinicians caring for HIV in older adults.

The FDA proposes to ease its lifetime ban on blood donations by men who have sex with men (MSM), but proposes to block donations by MSM within the last year. Here’s the rationale.

It turns out that where a patient gets a diagnosis of HIV affects how quickly he or she gets treatment for the infection.

Low-cost interventions can improve compliance with HIV therapy, which is directly linked to viral suppression and reduced transmission to partners.

If we had a vaccine that was as effective at reducing HIV infection as circumcision, it would be a recommended vaccine here in the US, argues this pediatrician.

Primary care clinicians take note: here’s a case for routine screening and treatment of early cryptococcal infection, given its prevalence and sequelae in patients with HIV/AIDS.

This AIDS specialist offers his rank-order list of the top 10 HIV clinical trials that really made a difference. The trials differ substantially in design, size, and focus, but they all were “game changers.”

Younger antiretroviral therapy enrollees differ from older ones in demographic and clinical characteristics and are at higher risk for loss to follow-up. But interventions could reduce mortality and incidence.

If full restoration of immunologic and clinical health is the goal of antiretroviral therapy, the best chance we have is to start ART within 12 months of infection.

Increasing clinical evidence suggests that statins may help prevent cancer in certain HIV-1–infected patients. Details here.

Immune reconstitution inflammatory syndrome is seen in some HIV-infected patients soon after initiation of antiretroviral therapy. The syndrome can “unmask” dormant opportunistic infections or aggravate existing infections.